Incorporating HIV/HCV Prevention, Screening, and Linkage to Care Into Opioid Use Disorder Treatment Settings

In this downloadable slideset, CCO’s expert faculty reviews important strategies for expanding addiction medicine services to include prevention, screening, diagnosis, and linkage to HCV and HIV care for patients with opioid use disorder.
Alain H. Litwin, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.42 MB
Released: September 18, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Produced in collaboration with
American Society of Addiction Medicine
Educational grant provided by:
Gilead Sciences

Related Content

Brief Clinical Care Options (CCO) video log of Monica Gandhi, MD, MPH, and her patient, Lisa, discussing bone health and HIVMA primary care guidance

Monica Gandhi, MD, MPH Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: March 4, 2021 Expired: March 3, 2022

Free expert-authored slides reviewing a patient case on HIV and bone health, as well as newly updated HIVMA primary care guidance for persons with HIV

Monica Gandhi, MD, MPH Released: March 4, 2021

Download CCO slides reviewing current/emerging strategies for HIV prevention, including current PrEP options and novel delivery systems

Joseph J. Eron, Jr., MD
Program Director
Princy N. Kumar, MD, FIDSA, MACP
Program Director
Gregory Huhn, MD, MPHTM
Released: March 3, 2021

Clinical Care Options (CCO) expert faculty Dr. Brenda Crabtree Ramírez discusses how the COVID-19 pandemic has reduced access to HIV care in México

Brenda E. Crabtree Ramírez, MD Released: March 2, 2021

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue